Previous 10 | Next 10 |
2024-05-03 07:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter of 2024, Baron Discovery Fund® (the Fund) was up 4.57% (...
2024-05-01 03:32:02 ET Inari Medical, Inc. (NARI) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants John Hsu - Vice President, Investor Relations Drew Hykes - Chief Executive Officer Mitch Hill - Chief Financial Officer Tom Tu ...
2024-04-30 17:08:43 ET More on Inari Medical Inari Medical: Buy On Growing TAM Inari Medical, Inc. (NARI) Q4 2023 Earnings Call Transcript Inari Medical, Inc. 2023 Q4 - Results - Earnings Call Presentation Piper Sandler cuts Inari to neutral; cites slowing gr...
2024-04-30 17:01:17 ET Gainers: Powell Industries ( POWL ) +19% . Root ( ROOT ) +16% . TransMedics Group ( TMDX ) +11% . Inari Medical ( NARI ) +7% . MannKind Corporation ( MNKD ) +5% . Losers: CVRx ( CVRX ) -16% ...
IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ende...
LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarte...
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Susta...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for potential violations of the federal securities l...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
SAN FRANCISCO, CA / ACCESSWIRE / June 14, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/inve...